Article
Nuclear survivin as a biomarker for non-small-cell lung cancer
13 Jul 2004
Abstract excerpt
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
